$381 Million is the total value of Altium Capital Management LP's 124 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 70.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GOEDWS | 1847 GOEDEKER INC*w exp 99/99/999 | $11,569,000 | -21.5% | 6,886,600 | 0.0% | 3.03% | -11.2% | |
| BLU | BELLUS HEALTH INC NEW | $10,983,000 | +97.4% | 1,788,789 | 0.0% | 2.88% | +123.3% | |
| CLDX | Buy | CELLDEX THERAPEUTICS INC NEW | $9,988,000 | +220.7% | 185,000 | +98.7% | 2.62% | +262.9% |
| CTIC | Sell | CTI BIOPHARMA CORP | $9,773,000 | +6.3% | 3,313,000 | -9.9% | 2.56% | +20.2% |
| ALDX | ALDEYRA THERAPEUTICS INC | $7,586,000 | -22.5% | 864,020 | 0.0% | 1.99% | -12.4% | |
| LNTH | Buy | LANTHEUS HLDGS INC | $7,447,000 | +12.2% | 290,000 | +20.8% | 1.95% | +26.9% |
| XTNT | Sell | XTANT MED HLDGS INC | $6,942,000 | -48.6% | 6,254,458 | -24.6% | 1.82% | -41.9% |
| VSTM | Buy | VERASTEM INC | $6,939,000 | -0.6% | 2,253,000 | +31.3% | 1.82% | +12.4% |
| CERS | Buy | CERUS CORP | $6,699,000 | +39.2% | 1,100,000 | +35.1% | 1.76% | +57.4% |
| CRIS | CURIS INC | $6,491,000 | -3.0% | 829,000 | 0.0% | 1.70% | +9.7% | |
| CTMX | Buy | CYTOMX THERAPEUTICS INC | $6,279,000 | +15.0% | 1,233,642 | +43.0% | 1.65% | +30.1% |
| IMTX | Buy | IMMATICS N.V | $6,227,000 | +55.7% | 478,987 | +39.0% | 1.63% | +76.0% |
| PTGX | Buy | PROTAGONIST THERAPEUTICS INC | $6,131,000 | -51.6% | 346,000 | +22.5% | 1.61% | -45.3% |
| ARQT | Buy | ARCUTIS BIOTHERAPEUTICS INC | $6,092,000 | -3.5% | 255,000 | +10.2% | 1.60% | +9.2% |
| INSP | Buy | INSPIRE MED SYS INC | $6,055,000 | +51.7% | 26,000 | +25.9% | 1.59% | +71.5% |
| NVRO | Buy | NEVRO CORP | $5,935,000 | +33.1% | 51,000 | +89.6% | 1.56% | +50.6% |
| KDNY | Buy | CHINOOK THERAPEUTICS INC | $5,933,000 | +0.9% | 465,000 | +11.6% | 1.56% | +14.1% |
| CDNA | Buy | CAREDX INC | $5,703,000 | -1.8% | 90,000 | +41.9% | 1.50% | +11.1% |
| SYRS | Buy | SYROS PHARMACEUTICALS INC | $5,688,000 | -3.1% | 1,272,412 | +18.2% | 1.49% | +9.6% |
| INSM | INSMED INC | $5,600,000 | -3.2% | 203,354 | 0.0% | 1.47% | +9.5% | |
| OCUL | Buy | OCULAR THERAPEUTIX INC | $5,560,000 | +53.1% | 556,000 | +117.1% | 1.46% | +73.2% |
| RNA | Buy | AVIDITY BIOSCIENCES INC | $5,542,000 | +18.9% | 225,000 | +19.3% | 1.45% | +34.5% |
| APLS | New | APELLIS PHARMACEUTICALS INCput | $5,494,000 | – | 166,700 | +100.0% | 1.44% | – |
| KLR | Sell | KALEYRA INC | $5,335,000 | -31.9% | 484,592 | -24.3% | 1.40% | -23.0% |
| ISEE | Sell | IVERIC BIO INC | $5,328,000 | -6.5% | 328,101 | -63.7% | 1.40% | +5.8% |
| HAE | Buy | HAEMONETICS CORP MASS | $5,224,000 | +47.9% | 74,000 | +39.6% | 1.37% | +67.3% |
| MYGN | Sell | MYRIAD GENETICS INC | $5,102,000 | -2.6% | 158,000 | -7.7% | 1.34% | +10.1% |
| NTRA | Buy | NATERA INC | $5,071,000 | +34.4% | 45,500 | +36.9% | 1.33% | +52.0% |
| MEIP | MEI PHARMA INC | $5,045,000 | -3.2% | 1,828,066 | 0.0% | 1.32% | +9.5% | |
| MBTC | NOCTURNE ACQUISITION CORPordinary shares | $4,990,000 | +1.2% | 500,000 | 0.0% | 1.31% | +14.4% | |
| KROS | New | KEROS THERAPEUTICS INC | $4,985,000 | – | 126,000 | +100.0% | 1.31% | – |
| AGLE | AEGLEA BIOTHERAPEUTICS INC | $4,847,000 | +14.2% | 609,689 | 0.0% | 1.27% | +29.2% | |
| CSTL | Buy | CASTLE BIOSCIENCES INC | $4,821,000 | -4.7% | 72,500 | +5.1% | 1.26% | +7.8% |
| VREX | Buy | VAREX IMAGING CORP | $4,456,000 | +17.6% | 158,000 | +11.8% | 1.17% | +33.0% |
| AVDL | AVADEL PHARMACEUTICALS PLCsponsored adr | $4,318,000 | +45.6% | 440,589 | 0.0% | 1.13% | +64.7% | |
| XFOR | New | X4 PHARMACEUTICALS INC | $4,256,000 | – | 804,598 | +100.0% | 1.12% | – |
| AFMD | New | AFFIMED N V | $4,110,000 | – | 665,000 | +100.0% | 1.08% | – |
| CRNX | Sell | CRINETICS PHARMACEUTICALS IN | $4,063,000 | -59.6% | 193,000 | -63.8% | 1.07% | -54.3% |
| ILMN | Buy | ILLUMINA INC | $4,056,000 | +7.1% | 10,000 | +25.0% | 1.06% | +21.2% |
| EUCR | EUCRATES BIOMEDICAL ACQU COR | $3,912,000 | -0.7% | 400,000 | 0.0% | 1.03% | +12.4% | |
| EYPT | EYEPOINT PHARMACEUTICALS INC | $3,861,000 | +15.9% | 370,551 | 0.0% | 1.01% | +31.0% | |
| BCYC | New | BICYCLE THERAPEUTICS PLCsponsored ads | $3,826,000 | – | 92,000 | +100.0% | 1.00% | – |
| ARCT | New | ARCTURUS THERAPEUTICS HLDGS | $3,822,000 | – | 80,000 | +100.0% | 1.00% | – |
| BBIO | New | BRIDGEBIO PHARMA INC | $3,703,000 | – | 79,000 | +100.0% | 0.97% | – |
| New | RENOVACOR INC | $3,519,000 | – | 388,845 | +100.0% | 0.92% | – | |
| PROF | Buy | PROFOUND MED CORP | $3,440,000 | 0.0% | 235,000 | +11.8% | 0.90% | +13.0% |
| ICAD | New | ICAD INC | $3,440,000 | – | 320,000 | +100.0% | 0.90% | – |
| TVTX | Sell | TRAVERE THERAPEUTICS INC | $3,419,000 | +37.5% | 141,000 | -17.3% | 0.90% | +55.5% |
| MORF | Buy | MORPHIC HLDG INC | $3,398,000 | +46.0% | 60,000 | +48.0% | 0.89% | +65.0% |
| XENE | Buy | XENON PHARMACEUTICALS INC | $3,300,000 | +14.3% | 216,000 | +39.4% | 0.87% | +29.4% |
| VRCA | Sell | VERRICA PHARMACEUTICALS INC | $3,203,000 | -46.0% | 256,244 | -51.2% | 0.84% | -39.0% |
| AUPH | Sell | AURINIA PHARMACEUTICALS INC | $3,187,000 | -25.2% | 144,000 | -56.2% | 0.84% | -15.5% |
| ADMS | Buy | ADAMAS PHARMACEUTICALS INC | $3,071,000 | +23.5% | 625,469 | +32.8% | 0.81% | +39.7% |
| TCON | New | TRACON PHARMACEUTICALS INC | $3,039,000 | – | 785,341 | +100.0% | 0.80% | – |
| MREO | MEREO BIOPHARMA GROUP PLCads | $3,025,000 | -23.7% | 1,250,000 | 0.0% | 0.79% | -13.7% | |
| GMED | Sell | GLOBUS MED INCcl a | $2,950,000 | -46.3% | 38,500 | -45.6% | 0.77% | -39.2% |
| New | DOUBLEDOWN INTERACTIVE CO LTads | $2,818,000 | – | 160,000 | +100.0% | 0.74% | – | |
| IGMS | IGM BIOSCIENCES INC | $2,793,000 | -21.0% | 42,473 | 0.0% | 0.73% | -10.6% | |
| KRMD | Buy | REPRO MED SYS INC | $2,719,000 | -19.4% | 954,055 | +31.0% | 0.71% | -8.8% |
| DYN | DYNE THERAPEUTICS INC | $2,706,000 | -22.8% | 166,636 | 0.0% | 0.71% | -12.7% | |
| FLUX | New | FLUX PWR HLDGS INC | $2,652,000 | – | 521,972 | +100.0% | 0.70% | – |
| CELC | CELCUITY INC | $2,610,000 | -25.0% | 145,000 | 0.0% | 0.68% | -15.1% | |
| HLXA | HELIX ACQUISITION CORP | $2,488,000 | -3.9% | 250,000 | 0.0% | 0.65% | +8.8% | |
| TMPM | TURMERIC ACQUISITION CORPcl a | $2,487,000 | -1.0% | 254,000 | 0.0% | 0.65% | +11.8% | |
| GRTX | Buy | GALERA THERAPEUTICS INC | $2,435,000 | +12.6% | 300,605 | +36.7% | 0.64% | +27.5% |
| PHAS | PHASEBIO PHARMACEUTICALS INC | $2,410,000 | -16.4% | 775,000 | 0.0% | 0.63% | -5.5% | |
| CRDF | Sell | CARDIFF ONCOLOGY INC | $2,324,000 | -30.4% | 348,888 | -30.5% | 0.61% | -21.2% |
| SRSA | New | SARISSA CAPITAL ACQUISITN COcl a | $2,219,000 | – | 225,000 | +100.0% | 0.58% | – |
| VQSLF | New | VIQ SOLUTIONS INC | $2,086,000 | – | 704,687 | +100.0% | 0.55% | – |
| SNDX | New | SYNDAX PHARMACEUTICALS INC | $2,064,000 | – | 108,000 | +100.0% | 0.54% | – |
| YMTX | Buy | YUMANITY THERAPEUTICS INC | $2,023,000 | +40.4% | 196,000 | +58.5% | 0.53% | +59.0% |
| FSII | FS DEVELOPMENT CORP II | $1,990,000 | -0.3% | 200,000 | 0.0% | 0.52% | +12.7% | |
| HCAQ | HEALTHCOR CATALIO ACQU CORP | $1,980,000 | +0.5% | 200,000 | 0.0% | 0.52% | +13.6% | |
| New | GIGINTERNATIONAL1 INC | $1,974,000 | – | 200,000 | +100.0% | 0.52% | – | |
| New | CHAVANT CAPITAL ACQUISITN COordinary shares | $1,970,000 | – | 200,000 | +100.0% | 0.52% | – | |
| New | LAKESHORE ACQUISITION I CORPordinary shares | $1,966,000 | – | 200,000 | +100.0% | 0.52% | – | |
| KALV | KALVISTA PHARMACEUTICALS INC | $1,952,000 | -27.2% | 111,834 | 0.0% | 0.51% | -17.7% | |
| JYAC | JIYA ACQUISITION CORP | $1,950,000 | -1.9% | 200,000 | 0.0% | 0.51% | +10.8% | |
| ELOX | Buy | ELOXX PHARMACEUTICALS INC | $1,822,000 | +36.6% | 1,118,000 | +66.8% | 0.48% | +54.7% |
| ONCR | New | ONCORUS INC | $1,794,000 | – | 192,054 | +100.0% | 0.47% | – |
| LFMD | New | LIFEMD INC | $1,793,000 | – | 288,700 | +100.0% | 0.47% | – |
| CMRX | New | CHIMERIX INC | $1,744,000 | – | 281,790 | +100.0% | 0.46% | – |
| VINC | VINCERX PHARMA INC | $1,740,000 | +24.5% | 107,625 | 0.0% | 0.46% | +40.7% | |
| New | HILLMAN SOLUTIONS CORP | $1,694,000 | – | 142,000 | +100.0% | 0.44% | – | |
| PRTG | PORTAGE BIOTECH INC | $1,524,000 | -3.1% | 75,000 | 0.0% | 0.40% | +9.6% | |
| EIGR | EIGER BIOPHARMACEUTICALS INC | $1,319,000 | -21.6% | 197,500 | 0.0% | 0.35% | -11.3% | |
| VRPX | New | VIRPAX PHARMACEUTICALS INC | $1,305,000 | – | 271,846 | +100.0% | 0.34% | – |
| FATBW | Sell | FAT BRANDS INC*w exp 07/16/202 | $1,297,000 | -41.8% | 227,000 | -2.9% | 0.34% | -34.2% |
| TWND | TAILWIND ACQUISITION CORP | $1,256,000 | -1.9% | 128,414 | 0.0% | 0.33% | +10.8% | |
| PODD | Sell | INSULET CORP | $1,208,000 | -74.1% | 4,250 | -75.0% | 0.32% | -70.7% |
| ACET | ADICET BIO INC | $1,116,000 | -23.8% | 142,289 | 0.0% | 0.29% | -13.8% | |
| CCAC | CITIC CAPITAL ACQUISITION CO | $1,109,000 | +0.6% | 111,200 | 0.0% | 0.29% | +13.7% | |
| New | STRYVE FOODS INC | $1,070,000 | – | 200,000 | +100.0% | 0.28% | – | |
| PRQR | New | PROQR THRAPEUTICS N V | $1,046,000 | – | 125,000 | +100.0% | 0.27% | – |
| ACHIEVE LIFE SCIENCES INC | $1,037,000 | -5.4% | 122,000 | 0.0% | 0.27% | +7.1% | ||
| MOTV | MOTIVE CAPITAL CORP | $1,011,000 | +1.3% | 102,099 | 0.0% | 0.26% | +14.7% | |
| New | ARYA SCIENCES ACQUISITN CORP | $1,005,000 | – | 100,000 | +100.0% | 0.26% | – | |
| BLSA | BCLS ACQUISITION CORP | $996,000 | -5.4% | 100,000 | 0.0% | 0.26% | +7.0% | |
| FMAC | FIRSTMARK HORIZON ACQUISITIO | $980,000 | -1.3% | 100,000 | 0.0% | 0.26% | +11.7% | |
| OMEG | OMEGA ALPHA SPACcl a | $974,000 | -2.1% | 100,000 | 0.0% | 0.26% | +10.4% | |
| ALNA | New | ALLENA PHARMACEUTICALS | $963,000 | – | 1,067,886 | +100.0% | 0.25% | – |
| New | COLISEUM ACQUISITION CORP | $846,000 | – | 85,000 | +100.0% | 0.22% | – | |
| CERE | New | CEREVEL THERAPEUTICS HLDNG Iput | $611,000 | – | 20,700 | +100.0% | 0.16% | – |
| ALGS | New | ALIGOS THERAPEUTICS INC | $519,000 | – | 33,492 | +100.0% | 0.14% | – |
| TCRR | Sell | TCR2 THERAPEUTICS INC | $503,000 | -85.3% | 59,150 | -71.7% | 0.13% | -83.4% |
| New | RENOVACOR INC*w exp 99/99/999 | $501,000 | – | 731,561 | +100.0% | 0.13% | – | |
| CLBR | New | COLOMBIER ACQUISITION CORPcl a | $484,000 | – | 50,000 | +100.0% | 0.13% | – |
| IMTXW | IMMATICS N.V*w exp 07/01/202 | $389,000 | +16.1% | 97,467 | 0.0% | 0.10% | +30.8% | |
| SCYX | New | SCYNEXIS INC | $371,000 | – | 70,000 | +100.0% | 0.10% | – |
| HCDIW | HARBOR CUSTOM DEVELOPMENT IN*w exp 05/09/202 | $351,000 | -7.1% | 600,000 | 0.0% | 0.09% | +4.5% | |
| KRYS | New | KRYSTAL BIOTECH INCcall | $303,000 | – | 5,800 | +100.0% | 0.08% | – |
| PSTX | New | POSEIDA THERAPEUTICS INC | $235,000 | – | 32,238 | +100.0% | 0.06% | – |
| MBTCR | NOCTURNE ACQUISITION CORPright 12/26/2025 | $210,000 | +10.5% | 500,000 | 0.0% | 0.06% | +25.0% | |
| EUCRW | EUCRATES BIOMEDICAL ACQU COR*w exp 10/23/202 | $107,000 | -23.0% | 133,333 | 0.0% | 0.03% | -12.5% | |
| HSAQ | HEALTH SCIENCES ACQ CORP 2 | $99,000 | -2.9% | 10,000 | 0.0% | 0.03% | +8.3% | |
| New | RESERVOIR MEDIA INC*w exp 08/26/202 | $99,000 | – | 50,000 | +100.0% | 0.03% | – | |
| New | SURROZEN INC*w exp 08/01/203 | $94,000 | – | 82,233 | +100.0% | 0.02% | – | |
| New | LAKESHORE ACQUISITION I CORP*w exp 07/15/202 | $79,000 | – | 150,000 | +100.0% | 0.02% | – | |
| SRSAW | New | SARISSA CAPITAL ACQUISITN CO*w exp 10/23/202 | $75,000 | – | 75,000 | +100.0% | 0.02% | – |
| New | CHAVANT CAPITAL ACQUISITN CO*w exp 99/99/999 | $72,000 | – | 150,000 | +100.0% | 0.02% | – | |
| TMPMW | TURMERIC ACQUISITION CORP*w exp 10/08/202 | $55,000 | -29.5% | 84,666 | 0.0% | 0.01% | -22.2% | |
| New | GIGINTERNATIONAL1 INC*w exp 04/19/202 | $37,000 | – | 50,000 | +100.0% | 0.01% | – | |
| CLBRWS | New | COLOMBIER ACQUISITION CORP*w exp 99/99/999 | $9,000 | – | 16,666 | +100.0% | 0.00% | – |
| UPHWS | UPHEALTH INC*w exp 06/08/202 | $5,000 | -44.4% | 10,000 | 0.0% | 0.00% | -50.0% | |
| BTTR | Exit | BETTER CHOICE CO INC | $0 | – | -20,000 | -100.0% | -0.02% | – |
| SNCR | Exit | SYNCHRONOSS TECHNOLOGIES INC | $0 | – | -32,500 | -100.0% | -0.03% | – |
| RCAT | Exit | RED CAT HLDGS INC | $0 | – | -102,290 | -100.0% | -0.06% | – |
| IKT | Exit | INHIBIKASE THERAPEUTICS INC | $0 | – | -109,749 | -100.0% | -0.07% | – |
| BCTXW | Exit | BRIACELL THERAPEUTICS CORP*w exp 02/24/202 | $0 | – | -209,540 | -100.0% | -0.09% | – |
| AHACW | Exit | ALPHA HEALTHCARE ACQUISTN CO*w exp 09/21/202 | $0 | – | -137,500 | -100.0% | -0.09% | – |
| CHAQWS | Exit | CHARDAN HEALTHCR ACQSTN 2 CO*w exp 03/05/202 | $0 | – | -731,561 | -100.0% | -0.11% | – |
| IFRX | Exit | INFLARX NV | $0 | – | -161,206 | -100.0% | -0.11% | – |
| ACEV | Exit | ACE CONVERGENCE ACQU CORPcl a | $0 | – | -48,530 | -100.0% | -0.11% | – |
| CLBRU | Exit | COLOMBIER ACQUISITION CORPunit 99/99/9999 | $0 | – | -50,000 | -100.0% | -0.12% | – |
| TKNO | Exit | ALPHA TEKNOVA INC | $0 | – | -25,000 | -100.0% | -0.14% | – |
| ONCT | Exit | ONCTERNAL THERAPEUTICS INC | $0 | – | -172,218 | -100.0% | -0.19% | – |
| MITAU | Exit | COLISEUM ACQUISITION CORPunit 04/02/2028 | $0 | – | -85,000 | -100.0% | -0.20% | – |
| VLON | Exit | VALLON PHARMACEUTICALS INC | $0 | – | -161,440 | -100.0% | -0.20% | – |
| HEPA | Exit | HEPION PHARMACEUTICALS INC | $0 | – | -446,000 | -100.0% | -0.20% | – |
| INMB | Exit | INMUNE BIO INC | $0 | – | -52,257 | -100.0% | -0.21% | – |
| COCP | Exit | COCRYSTAL PHARMA INC | $0 | – | -776,000 | -100.0% | -0.22% | – |
| SPNV | Exit | SUPERNOVA PARTNERS ACQUISITI | $0 | – | -100,000 | -100.0% | -0.23% | – |
| QELL | Exit | QELL ACQUISITION CORPcl a | $0 | – | -100,000 | -100.0% | -0.23% | – |
| IRTC | Exit | IRHYTHM TECHNOLOGIES INC | $0 | – | -15,206 | -100.0% | -0.23% | – |
| ARYD | Exit | ARYA SCIENCES ACQU CORP IVcl a | $0 | – | -100,000 | -100.0% | -0.25% | – |
| AJAX | Exit | AJAX I | $0 | – | -125,000 | -100.0% | -0.29% | – |
| PCTTW | Exit | PURECYCLE TECHNOLOGIES INC*w exp 01/28/202 | $0 | – | -130,875 | -100.0% | -0.37% | – |
| KRBP | Exit | KIROMIC BIOPHARMA INC | $0 | – | -333,475 | -100.0% | -0.37% | – |
| CYTK | Exit | CYTOKINETICS INC | $0 | – | -84,262 | -100.0% | -0.39% | – |
| CVRX | Exit | CVRX INC | $0 | – | -60,000 | -100.0% | -0.39% | – |
| IMCC | Exit | IM CANNABIS CORP | $0 | – | -321,845 | -100.0% | -0.40% | – |
| EYES | Exit | SECOND SIGHT MED PRODS INC | $0 | – | -373,867 | -100.0% | -0.43% | – |
| GIWWU | Exit | GIGINTERNATIONAL1 INCunit 05/19/2026 | $0 | – | -200,000 | -100.0% | -0.47% | – |
| TARS | Exit | TARSUS PHARMACEUTICALS INC | $0 | – | -70,573 | -100.0% | -0.47% | – |
| LAAAU | Exit | LAKESHORE ACQUISITION I CORPunit 06/04/2026 | $0 | – | -200,000 | -100.0% | -0.47% | – |
| RYTM | Exit | RHYTHM PHARMACEUTICALS INC | $0 | – | -104,840 | -100.0% | -0.48% | – |
| CARA | Exit | CARA THERAPEUTICS INC | $0 | – | -150,000 | -100.0% | -0.50% | – |
| FULC | Exit | FULCRUM THERAPEUTICS INC | $0 | – | -213,533 | -100.0% | -0.52% | – |
| SRSAU | Exit | SARISSA CAPITAL ACQUISITN COunit 10/23/2027 | $0 | – | -225,000 | -100.0% | -0.54% | – |
| SRGA | Exit | SURGALIGN HOLDINGS INC | $0 | – | -1,739,131 | -100.0% | -0.56% | – |
| RGNX | Exit | REGENXBIO INC | $0 | – | -62,317 | -100.0% | -0.56% | – |
| MCRB | Exit | SERES THERAPEUTICS INC | $0 | – | -104,626 | -100.0% | -0.58% | – |
| LSAQ | Exit | LIFESCI ACQUISITION II CORP | $0 | – | -250,000 | -100.0% | -0.58% | – |
| INFI | Exit | INFINITY PHARMACEUTICALS INC | $0 | – | -934,327 | -100.0% | -0.65% | – |
| AHAC | Exit | ALPHA HEALTHCARE ACQUISTN COcl a | $0 | – | -275,000 | -100.0% | -0.65% | – |
| STIM | Exit | NEURONETICS INC | $0 | – | -184,554 | -100.0% | -0.69% | – |
| XENT | Exit | INTERSECT ENT INC | $0 | – | -182,456 | -100.0% | -0.72% | – |
| TBPH | Exit | THERAVANCE BIOPHARMA INC | $0 | – | -220,000 | -100.0% | -0.74% | – |
| GKOS | Exit | GLAUKOS CORP | $0 | – | -40,400 | -100.0% | -0.80% | – |
| NSTG | Exit | NANOSTRING TECHNOLOGIES INC | $0 | – | -54,500 | -100.0% | -0.82% | – |
| IMVT | Exit | IMMUNOVANT INC | $0 | – | -335,041 | -100.0% | -0.82% | – |
| BCTX | Exit | BRIACELL THERAPEUTICS CORP | $0 | – | -800,295 | -100.0% | -0.99% | – |
| SIEN | Exit | SIENTRA INC | $0 | – | -605,691 | -100.0% | -1.12% | – |
| ECOR | Exit | ELECTROCORE INC | $0 | – | -5,000,000 | -100.0% | -1.38% | – |
| EPIX | Exit | ESSA PHARMA INC | $0 | – | -213,528 | -100.0% | -1.42% | – |
| PALI | Exit | PALISADE BIO INC | $0 | – | -1,824,894 | -100.0% | -1.72% | – |
| CHAQ | Exit | CHARDAN HEALTHCR ACQSTN 2 CO | $0 | – | -753,874 | -100.0% | -1.74% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2021-11-17
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| FAT BRANDS INC | 12 | Q3 2023 | 0.6% |
| CHINOOK THERAPEUTICS INC | 11 | Q2 2023 | 8.9% |
| BELLUS HEALTH INC NEW | 10 | Q1 2023 | 4.7% |
| XTANT MED HLDGS INC | 10 | Q3 2023 | 5.1% |
| IVERIC BIO INC | 10 | Q1 2023 | 2.3% |
| MYRIAD GENETICS INC | 10 | Q1 2023 | 2.3% |
| HARBOR CUSTOM DEVELOPMENT IN | 10 | Q3 2023 | 0.1% |
| CRINETICS PHARMACEUTICALS IN | 9 | Q3 2023 | 4.1% |
| CTI BIOPHARMA CORP | 9 | Q1 2023 | 2.6% |
| POLISHED COM INC | 9 | Q2 2023 | 3.4% |
View Altium Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Marpai, Inc. | April 26, 2023 | 1,805,327 | 6.2% |
| Astria Therapeutics, Inc. | February 14, 2023 | 1,355,372 | 5.0% |
| HyreCar Inc. | February 14, 2023 | 1,688,120 | 5.6% |
| Muscle Maker, Inc. | February 14, 2023 | 2,888,085 | 5.0% |
| NeuroBo Pharmaceuticals, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| PALISADE BIO, INC.Sold out | February 14, 2023 | 0 | 0.0% |
| 1847 Goedeker Inc. | February 14, 2022 | 6,103,824 | 5.0% |
| BioRestorative Therapies, Inc. | February 14, 2022 | 200,000 | 5.0% |
| BriaCell Therapeutics Corp. | February 14, 2022 | 900,000 | 4.7% |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. | February 14, 2022 | 363,000 | 5.0% |
View Altium Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-02-21 |
| SC 13G | 2024-02-20 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
View Altium Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.